Related Experiment Video
Updated: Jan 13, 2026

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
Predicting cardiovascular outcomes in elderly patients with acute coronary syndrome: a nomogram approach
Hamidreza Soleimani1, Reza Nikfar2, Sahand Siami2
1Imam Khomeini Hospital Complex Tehran University of Medical Science.
Insights
A new nomogram accurately predicts Major Adverse Cardiovascular Events (MACE) in elderly patients with ST Elevation Myocardial Infarction (STEMI) after primary PCI, identifying high-risk individuals for targeted interventions.
Area of Science:
- Cardiology
- Geriatric Medicine
- Medical Informatics
Background:
- ST Elevation Myocardial Infarction (STEMI) remains a significant concern for elderly patients, with a notable risk of Major Adverse Cardiovascular Events (MACE) despite advancements in diagnosis and treatment.
- Identifying high-risk individuals within this demographic is crucial for improving patient outcomes.
Purpose of the Study:
- To develop and validate a predictive nomogram for MACE incidence in elderly STEMI patients undergoing primary Percutaneous Coronary Intervention (PCI).
- To identify key clinical, laboratory, and procedural factors associated with MACE in this population.
Main Methods:
- Retrospective analysis of 65-year-old STEMI patients who underwent primary PCI at Tehran Heart Center.
- Inclusion of demographic, laboratory, clinical, and intra-procedural data.
- Application of univariate and multivariate analyses, decision curve analysis, ROC curves, and calibration plots for nomogram validation using R Studio.
Main Results:
- A nomogram was constructed using 8 significant factors: left-ventricular ejection fraction (LVEF), serum creatinine, hemoglobin, fasting blood glucose, valvular heart disease, post-PCI TIMI flow grade, culprit lesion stent diameter, and post-PCI shock.
- The nomogram demonstrated good predictive performance with an Area Under the Curve (AUC) of 71% for MACE prediction.
- The model showed strong calibration and discriminative ability, validated on a separate testing cohort.
Conclusions:
- A validated nomogram effectively predicts MACE risk in older STEMI patients based on readily available clinical, laboratory, and procedural data.
- This predictive tool can aid clinicians in identifying vulnerable patients who may benefit from more intensive preventative strategies.
Background:
Although ST Elevation Myocardial Infarction (STEMI) diagnosis and therapy have improved, high-risk categories like elderly persons still have a significant chance of MACE despite treatment.
Objectives:
This study attempts to construct a predictive nomogram for MACE incidence using clinical data from a STEMI registry.
Methods:
Tehran Heart Center's computerized record recognized all 65-year-old STEMI primary PCI patients consecutively. This retrospective study examined demographic, laboratory, clinical, and intra-procedural factors. Post-PCI univariate and multivariate analyses identified MACE risk variables. Decision curve analysis, ROC, and calibration plots validated predictive nomograms. R Studio and R used "tidyverse" and "rms" packages for all analyses.
Results:
The 1946 study included 70% training and 30% testing patients. Basic demographic and clinical variables were identical for both groups. The average follow-up was 17 months. 8 factors were selected for the nomogram after univariate and multivariate analysis: left-ventricular ejection fraction (LVEF), serum creatinine, hemoglobin, and fasting blood glucose levels, presence of valvular heart disease, post-PCI TIMI flow grade, diameter of the culprit lesion stent, and presence or absence of shock after PCI. The post-PCI MACE prediction AUC was 71%. Calibration plots showed that the nomogram model was well-calibrated and close to observed outcomes. Decision curve analysis also revealed that the model predicted MACE discriminatively.
Conclusion:
A nomogram successfully predicts MACE risk in older STEMI patients using laboratory, clinical, and procedural parameters. This algorithm may identify vulnerable high-risk patients for more aggressive preventative interventions.
Clinical Trial Number:
not applicable.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Dosage Regimen Designs: Nomograms and Tabulations
Acute Coronary Syndrome V: Nursing Management
Acute Coronary Syndrome IV: Interprofessional Care
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome I: Introduction

